---
title: "Gujarat Themis Biosyn Ltd (GUJTHEM) — Share Price, Financials & Analysis"
symbol: "GUJTHEM"
company: "Gujarat Themis Biosyn Ltd"
canonical: "https://tapetide.com/stocks/GUJTHEM"
isin: "INE942C01045"
nse_symbol: "GUJTHEM"
bse_code: "506879"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 4554.75
generated_at: "2026-09-13T19:16:04.564Z"
---

# Gujarat Themis Biosyn Ltd (GUJTHEM)

Canonical page: https://tapetide.com/stocks/GUJTHEM

## Company

- **NSE Symbol:** GUJTHEM
- **BSE Code:** 506879
- **ISIN:** INE942C01045
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2025-02-25
- **CEO:** Dr. Sachin Dinesh Patel CChem., Ph.D.
- **Employees:** 221
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** gtbl.in

## About

Incorporated in 1981, Gujarat Themis Biosyn 
Ltd manufactures and sells finished Active Pharmaceutical Ingredients products by fermentation process[1]

## Latest Price

- **Price:** ₹422.65
- **Change:** -7.45 (-1.73%)
- **Open:** ₹430
- **Day High:** ₹430
- **Day Low:** ₹413.6
- **Previous Close:** ₹430.1
- **Volume:** 390855
- **As Of:** 2026-09-11T10:25:55+00:00

## Key Fundamentals

Observed at 2026-09-11T04:38:24.595643Z.

- **Market Cap:** ₹4554.75 Cr
- **Classification:** Microcap
- **P/E (reported):** 120
- **P/E (TTM):** 94.55
- **EPS (TTM):** ₹4.47
- **Book Value:** ₹58.18
- **Price to Book:** 7.4
- **Dividend Yield:** 0.16%
- **ROE:** 19.64%
- **ROCE:** 23.47%
- **Debt to Equity:** 0.56
- **Revenue (yearly):** ₹165.82 Cr
- **Net Income:** ₹51.3 Cr
- **EBITDA:** ₹75.53 Cr
- **52-Week High:** ₹479
- **52-Week Low:** ₹225.05
- **RSI (14):** 60.32

## Tapetide Score

- **Score:** 49 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Rising
- **Percentile:** 43.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 62.46 | 9% |
| growth | 64.06 | 9% |
| momentum | 63.65 | 12% |
| ownership | 46.54 | 24% |
| quality | 68.55 | 22% |
| valuation | 18.25 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has a good return on equity (ROE) track record: 3 Years ROE 23.1%

### Weaknesses

- Stock is trading at 16.0 times its book value
- Promoter holding has decreased over last quarter: -11.5%
- Company might be capitalizing the interest cost
- Debtor days have increased from 89.3 to 134 days.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 41.77% | 130.57% | 764.48% |
| ebitda margin growth | 2.96% | -3.98% | -5.91% | -14.04% |
| net income growth | 1.83% | 5.12% | -7% | 9% |
| revenue growth | -2.66% | 8.73% | 4% | 13% |
| roce | — | -39.54% | -54.34% | 45.66% |
| roe | — | -33.15% | 29.3% | -54.48% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 40 | 39 | 42 | 39 | 35 | 40 | 38 | 36 | 42 | 43 | 44 | 44 |
| Expenses | 23 | 21 | 21 | 20 | 19 | 21 | 22 | 22 | 21 | 22 | 25 | 23 |
| Operating Profit | 17 | 18 | 21 | 19 | 15 | 19 | 16 | 14 | 21 | 21 | 19 | 21 |
| OPM % | 42 | 46 | 50 | 48 | 44 | 48 | 42 | 39 | 49 | 49 | 44 | 48 |
| Other Income | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 3 | 4 | 4 | 4 |
| Profit before tax | 17 | 18 | 21 | 18 | 14 | 17 | 16 | 12 | 19 | 17 | 14 | 15 |
| Tax % | 26 | 26 | 24 | 26 | 26 | 25 | 25 | 25 | 24 | 26 | 24 | 27 |
| Net Profit | 13 | 13 | 16 | 13 | 11 | 13 | 12 | 9 | 14 | 12 | 11 | 11 |
| EPS in Rs | 1.15 | 1.19 | 1.46 | 1.21 | 0.97 | 1.19 | 1.1 | 0.83 | 1.31 | 1.14 | 1 | 1.02 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 39 | 41 | 85 | 91 | 115 | 148 | 170 | 151 | 166 | 174 |
| Expenses | 33 | 34 | 53 | 50 | 57 | 75 | 91 | 82 | 89 | 91 |
| Operating Profit | 6 | 7 | 32 | 40 | 58 | 74 | 79 | 69 | 76 | 82 |
| OPM % | 16 | 18 | 37 | 45 | 51 | 50 | 46 | 46 | 46 | 47 |
| Other Income | 0 | 2 | 2 | 3 | 4 | 7 | 4 | 2 | 2 | 2 |
| Interest | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 4 | 5 |
| Depreciation | 1 | 1 | 1 | 2 | 2 | 3 | 4 | 5 | 13 | 15 |
| Profit before tax | 5 | 8 | 31 | 41 | 59 | 77 | 79 | 66 | 62 | 65 |
| Tax % | 20 | 22 | 24 | 26 | 26 | 25 | 25 | 26 | 25 | — |
| Net Profit | 4 | 6 | 24 | 30 | 44 | 58 | 59 | 49 | 47 | 49 |
| EPS in Rs | 0.36 | 0.59 | 2.17 | 2.77 | 4 | 5.32 | 5.43 | 4.48 | 4.28 | 4.47 |
| Dividend Payout % | 0 | 0 | 10 | 0 | 37 | 14 | 12 | 15 | 16 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 11 | 11 |
| Reserves | 1 | 5 | 11 | 35 | 63 | 96 | 142 | 194 | 237 | 277 |
| Borrowings | 4 | 1 | 6 | 8 | 5 | 1 | 0 | 3 | 30 | 162 |
| Other Liabilities | 9 | 8 | 8 | 14 | 14 | 18 | 17 | 17 | 22 | 54 |
| Total Liabilities | 21 | 20 | 33 | 64 | 88 | 122 | 166 | 221 | 301 | 503 |
| Fixed Assets | 11 | 11 | 15 | 17 | 19 | 19 | 33 | 38 | 41 | 289 |
| CWIP | 0 | 0 | 1 | 0 | 2 | 13 | 21 | 91 | 184 | 121 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 11 | 10 | 17 | 47 | 67 | 90 | 113 | 92 | 76 | 93 |
| Total Assets | 21 | 20 | 33 | 64 | 88 | 122 | 166 | 221 | 301 | 503 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 3 | 6 | 1 | 1 | 11 | 40 | 39 | 64 | 91 | 49 |
| Cash from Investing Activity | -3 | -1 | -6 | -3 | -2 | -30 | -20 | -55 | -112 | -172 |
| Cash from Financing Activity | 0 | -4 | 5 | 2 | -5 | -14 | -13 | -9 | 26 | 115 |
| Net Cash Flow | 0 | 1 | 0 | 0 | 3 | -4 | 6 | 0 | 5 | -9 |
| Free Cash Flow | 0 | 5 | -5 | -3 | 7 | 26 | 16 | -10 | -25 | -124 |
| CFO/OP | 57 | 99 | 25 | 24 | 51 | 94 | 81 | 107 | 156 | 78 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 71 | 26 | 52 | 87 | 59 | 80 | 44 | 58 | 76 | 134 |
| Inventory Days | — | 78 | — | 194 | 144 | 255 | 201 | 33 | 75 | 263 |
| Days Payable | — | 947 | — | 240 | 84 | 145 | 131 | 99 | 218 | 625 |
| Cash Conversion Cycle | 71 | -844 | 52 | 41 | 119 | 189 | 114 | -7 | -67 | -228 |
| Working Capital Days | -42 | -43 | -58 | 42 | 80 | 155 | 91 | 50 | 46 | 8 |
| ROCE % | 55 | 42 | 45 | 84 | 67 | 67 | 61 | 45 | 27 | 18 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 74.99% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% | 70.86% |
| FIIs | 0.01% | 0% | 1.05% | 1.44% | 1.49% | 1.42% | 1.91% | 2.51% | 2.95% | 1.96% | 1.8% | 1.77% |
| DIIs | 0.03% | 0.02% | 0.82% | 1.18% | 1.17% | 1.17% | 1.17% | 1.17% | 1.17% | 1.17% | 1.18% | 1.18% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 21.85% | 23.4% | 22.26% | 21.17% | 20.44% | 20.12% | 19.66% | 19.31% | 18.72% | 19.9% | 19.88% | 19.46% |
| Others | 3.11% | 5.71% | 5% | 5.35% | 6.03% | 6.42% | 6.39% | 6.14% | 6.29% | 6.1% | 6.28% | 6.73% |
| No. of Shareholders | 19846 | 28655 | 29576 | 30280 | 31271 | 30934 | 30673 | 28945 | 28319 | 27325 | 26886 | 27010 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 12 / 5 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 425.77 | Sell |
| EMA (10) | 423.47 | Sell |
| SMA (20) | 408.17 | Buy |
| EMA (20) | 410.71 | Buy |
| SMA (50) | 381.07 | Buy |
| EMA (50) | 391.42 | Buy |
| SMA (100) | 381.47 | Buy |
| EMA (100) | 378.53 | Buy |
| SMA (200) | 361.39 | Buy |
| EMA (200) | 365.29 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 57.13 | Neutral |
| MACD (12,26,9) | 15.97 | Buy |
| Stochastic (14,3,3) | 50.92 | Neutral |
| ADX (14) | 44.63 | Buy |
| Williams %R (14) | -60.73 | Neutral |
| ATR (14) | 21.04 | High Volatility |
| ROC (12) | 0.45 | Buy |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 42.66 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-09-10 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 10.09.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2c8ffd27-cb8e-4b5b-be00-4ff2a46126c6.pdf) |
| 2026-09-08 | [Addendum To The Notice Of 45Th Annual General Meeting (AGM)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2b5fef3a-5e06-40b1-a04c-f79ce2017d17.pdf) |
| 2026-09-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32fc679b-73d6-4169-acba-b9f968d2e58a.pdf) |
| 2026-09-07 | [Board Meeting Intimation for Raising Funds Through Issue Of Non-Convertible Debentures By Way Of Private Placement.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1bad5fd4-f3c6-45f0-906e-9961e6e4cd60.pdf) |
| 2026-09-04 | [Shareholders Meeting - AGM On 30.09.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6ea7fa21-a500-4b56-aca5-80137f4f5db0.pdf) |
| 2026-09-04 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c6d47c7-f158-45ce-9981-40fc5cca7e86.pdf) |
| 2026-09-04 | [Business Responsibility and Sustainability Reporting (BRSR)](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32d27ac6-20fa-4512-97c8-54b4ecf8292c.pdf) |
| 2026-09-02 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=A1A501D9_23AC_4D81_8CA3_05DF4D0EA62E_113546.pdf) |
| 2026-09-01 | [Board Meeting Outcome for Outcome Of The Board Meeting Held On 01-09-2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5d5b9047-a0cf-4421-aa34-5d683d75d4d7.pdf) |
| 2026-08-28 | [Announcement under Regulation 30 (LODR)-Qualified Institutional Placement](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1796afe9-3665-458d-8934-bccaa684d2f3.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=643eb2c9-099b-412c-8752-0f9d817c415e.pdf) |
| 2023-11-10 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aaef3cb8-0870-4c3b-9e11-a79200235997.pdf) |
| 2023-05-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6dda6542-2d69-45a2-ad54-5f893c58a564.pdf) |
| 2023-02-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5b32ae0b-ab9c-40ef-bbc4-2b192222f44b.pdf) |
| 2022-11-21 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bb57963-fa06-4f09-9304-e4c994e2183b.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-07 | [Results- Unaudited Standalone And Consolidated Financial Results For The Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bab3973d-a237-48f8-9d78-54fbd29abec2.pdf) |
| 2026-05-25 | [Results - Audited Financial Results For The Quarter And Year Ended 31.03.2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9677d395-6e13-48cf-a43f-5f7974d3a786.pdf) |
| 2026-02-05 | [Results - Financial Results For The Quarter And Nine Months Ended 31.12.2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4ca23e6a-1504-4cce-965a-0fe8dc1c1352.pdf) |
| 2025-11-10 | [Results - Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=402f8213-9a7e-4c47-8495-e0ac6a3d283e.pdf) |
| 2025-08-01 | [Un-Audited Financial Results For The Quarter Ended 30Th June 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=242f98a4-f681-464c-9db5-ceaf8ce5607f.pdf) |
| 2025-05-20 | [Audited Financial Results For The Quarter And Year Ended 31St March 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b470e68-dd9b-4d36-a14d-c73784157aae.pdf) |
| 2025-02-14 | [Results - Financial Results For The Quarter And Nine Months Ended 31.12.2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98a23f89-c78f-4467-951c-345fdc5daff5.pdf) |
| 2024-10-25 | [Results: Financial Results For The Quarter And Half Year Ended 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d842b02-08db-42b2-89a3-093efc69e8ff.pdf) |
| 2024-07-26 | [Results - Financial Results For The Quarter Ended 30Th June, 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=73902fae-bbca-49f7-955e-137171712c5c.pdf) |
| 2024-05-14 | [Financial Results For The Quarter And Year Ended 31 March 2024.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cb1beeb7-ca83-4626-822f-e23493d3ce25.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16ef5857-cc4e-479c-aa56-508b84e48f97.pdf) |
| 2026-06-29 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=572e2ea2-2abf-4998-bb0c-3fb2b12b31be.pdf) |
| 2026-05-25 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=50d6779f-9dec-4b9b-821f-2f41eaebb1b2.pdf) |
| 2026-05-22 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff3ab1d6-ee68-408e-bab2-554523e88958.pdf) |
| 2026-04-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2230b114-c615-4129-b7c9-accef92a84e5.pdf) |
| 2026-02-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fd6da361-2bce-497d-936b-de6a8697c8fb.pdf) |
| 2025-11-10 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db6134ec-e213-4991-8912-9b4eca8a2d39.pdf) |
| 2025-08-01 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c1776c04-b5dc-4d66-a742-07c82bd921e5.pdf) |
| 2025-05-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c7c83f0-8bfb-4fee-9214-6ef1b41a49cd.pdf) |
| 2025-02-14 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=712afa55-f8c7-4e97-aaaf-ab72e4c35420.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - RTA Compliance Certificate under Regulation 74(5) for the quarter ended 31.03.2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - RTA Compliance Certificate under Regulation 74(5) for the quarter ended 31.03.2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/04767cad-ce02-4aae-b279-fd99d32d1a45.pdf) |
| 8 Apr - Newspaper Publication of Notice to Shareholders for Special Window for re-lodgement of transfer requests and dematerialization of physical shares. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Apr - Newspaper Publication of Notice to Shareholders for Special Window for re-lodgement of transfer requests and dematerialization of physical shares.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c66268df-1fd2-4172-9448-ba0100bdfe36.pdf) |
| 6 May - Refer to the copy of Newspaper Publication of Postal Ballot Notice. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 6 May - Refer to the copy of Newspaper Publication of Postal Ballot Notice.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/591ee580-8406-4c39-8452-cb180f243aed.pdf) |
| 5 May - Postal ballot seeks Rs 3,500 crore borrowing and investment limits; e-voting runs May 6-June 4, 2026. | [Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 5 May - Postal ballot seeks Rs 3,500 crore borrowing and investment limits; e-voting runs May 6-June 4, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/8f566f78-f0dc-46b2-a9ae-1f2766962dad.pdf) |
| 5 Feb - Unaudited Q3/9M results (Q3 revenue INR 4,378.45L; Q3 net profit INR 1,246.46L); new CFO Krupesh Patel effective April 1, 2026. | [Results - Financial Results For The Quarter And Nine Months Ended 31.12.2025 5 Feb - Unaudited Q3/9M results (Q3 revenue INR 4,378.45L; Q3 net profit INR 1,246.46L); new CFO Krupesh Patel effective April 1, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4ca23e6a-1504-4cce-965a-0fe8dc1c1352.pdf) |
| 3h - GTBL to acquire Sanofi's 13-product anti-TB/anti-infective portfolio for EUR 158 million, expected to close by Q3FY27. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 3h - GTBL to acquire Sanofi's 13-product anti-TB/anti-infective portfolio for EUR 158 million, expected to close by Q3FY27.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/62b52828-5ccf-4722-a363-899a2bf9daa4.pdf) |
| 3h - GTBL signs €158 million asset purchase agreement to acquire 13 branded generic products from Sanofi. | [Announcement under Regulation 30 (LODR)-Acquisition 3h - GTBL signs €158 million asset purchase agreement to acquire 13 branded generic products from Sanofi.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/03eba62f-3628-493b-8a4f-03a46042d5c0.pdf) |
| 23 Apr - GTBL to acquire Sanofi's 13-product anti-TB/anti-infective portfolio for EUR 158 million, expected to close by Q3FY27. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 23 Apr - GTBL to acquire Sanofi's 13-product anti-TB/anti-infective portfolio for EUR 158 million, expected to close by Q3FY27.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/62b52828-5ccf-4722-a363-899a2bf9daa4.pdf) |
| 23 Apr - GTBL signs €158 million asset purchase agreement to acquire 13 branded generic products from Sanofi. | [Announcement under Regulation 30 (LODR)-Acquisition 23 Apr - GTBL signs €158 million asset purchase agreement to acquire 13 branded generic products from Sanofi.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/03eba62f-3628-493b-8a4f-03a46042d5c0.pdf) |
| 19 Mar - Newspaper Publication of Postal Ballot Notice dated 18.03.2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 19 Mar - Newspaper Publication of Postal Ballot Notice dated 18.03.2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7f14b909-ffb0-44ac-958d-a8120f09e39d.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c2585f02-e883-4c11-ae50-40f8e2c8cee3.pdf) |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/db6134ec-e213-4991-8912-9b4eca8a2d39.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aaef3cb8-0870-4c3b-9e11-a79200235997.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4bb57963-fa06-4f09-9304-e4c994e2183b.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/50d6779f-9dec-4b9b-821f-2f41eaebb1b2.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ff3ab1d6-ee68-408e-bab2-554523e88958.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/50d6779f-9dec-4b9b-821f-2f41eaebb1b2.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/ff3ab1d6-ee68-408e-bab2-554523e88958.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1c7c83f0-8bfb-4fee-9214-6ef1b41a49cd.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/29e2e72f-c184-490c-96be-a9c3464e3170.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e377f564-a6fe-417c-96d7-d9a64b7e4b5f.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6d23ec96-4c61-4dfe-899f-ba3639b56fbb.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/70b55898-d052-4119-97ff-57cd2f524561.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2023-05-15 | [Audio Recording Of The Earnings Conference Call For Q4 & FY23](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3de40cd4-1bfa-4a8f-8b67-1b841d998825.pdf) |
| 2023-02-06 | [Audio Recording Of The Earnings Conference Call For Q3 &9M FY23](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=147943ec-8072-4d25-8c09-6f76287f45ca.pdf) |
| 2022-11-16 | [Audio Recording Of The Maiden Earnings Conference Call For Q2 & H1 FY23 Held On 16.11.2022](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0f7571d-f22d-4496-807d-accb24d2d917.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:16:04.564Z.